Evidence map›Paper›PMID 42631696›Full record

ArticleACS chemical biology2026

Efforts Toward XNA PCR: Optimization and Characterization of PCR-Amplification of Chimeric 2'F XNA/DNA.

Helen V Branson, Aria A Khalique, Mia J Kronson, Delaney I Carlin, Avery E Roof, Madison K C Seto, Ysabel David, Michelle Cao, Susanna E Barrett, Taiasean Wu and 1 more

Abstract read
In one paragraph

Article in ACS chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Helen V BransonDepartment of Natural Sciences of Pitzer and Scripps College , Claremont, California91711, United States of America.
Aria A KhaliqueDepartment of Natural Sciences of Pitzer and Scripps College , Claremont, California91711, United States of America.
Mia J KronsonDepartment of Natural Sciences of Pitzer and Scripps College , Claremont, California91711, United States of America.
Delaney I CarlinDepartment of Natural Sciences of Pitzer and Scripps College , Claremont, California91711, United States of America.
Avery E RoofDepartment of Natural Sciences of Pitzer and Scripps College , Claremont, California91711, United States of America.
Madison K C SetoDepartment of Natural Sciences of Pitzer and Scripps College , Claremont, California91711, United States of America.
Ysabel DavidDepartment of Natural Sciences of Pitzer and Scripps College , Claremont, California91711, United States of America.
Michelle CaoDepartment of Natural Sciences of Pitzer and Scripps College , Claremont, California91711, United States of America.
Susanna E BarrettDepartment of Natural Sciences of Pitzer and Scripps College , Claremont, California91711, United States of America.
Taiasean WuDepartment of Natural Sciences of Pitzer and Scripps College , Claremont, California91711, United States of America.
Aaron M LeconteDepartment of Natural Sciences of Pitzer and Scripps College , Claremont, California91711, United States of America.ORCID 0000-0002-5789-9147

Funding

Division of Chemistry CHE-1752924Research Corporation for Science Advancement CS-SEED-2004-006Research Corporation for Science Advancement CS-SEED-2024-006
6 · The paper itself

Abstract

Xeno Nucleic Acids (XNA) are chemically modified versions of DNA. These modifications can bypass natural immune responses and impart novel properties in complex biological systems. Previous efforts have identified mutant proteins capable of robust XNA synthesis; one mutant, SFM4-3, has been shown to be able to amplify partially substituted XNA in the polymerase chain reaction (PCR) which is necessary for many applications of XNA. However, SFM4-3 mediated PCR is inefficient and has required up to 22 h of reaction time to create amplicons of ∼75 nucleotides (nt); optimizing the PCR amplification of XNA can potentially improve its utility. Here, we show an optimized method for XNA PCR and compare the XNA PCR ability of mutant XNA polymerase enzymes. We show that SFP1 and SFP4 perform better than SFM4-3 in the amplification of 2'F-XNA. We also highlight the role of protein stability in XNA polymerase PCR performance, demonstrating that significantly diminished thermostability may limit current XNA polymerases. This work decreases the time needed for XNA PCR to <4 h, increases the length of amplicons generated to 245 nt, identifies new PCR-active enzymes, and provides guidance for how to improve XNA polymerases for PCR in the future.

Indexed as

DNAPolymerase Chain ReactionDNA-Directed DNA PolymeraseDNADNA-Directed DNA Polymerase

Identifiers

PMID42631696
PMCPMC13505186

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.